ISPOR - PDB37 IS INSULIN GLARGINE A COST-EFFECTIVE OPTION FOR TREATMENT OF PATIENTS NA AND AGE BELOW 65YEARS IN COMPARISON TO NPH AND PREMIX IN POLAND?

Full Text

PDB37 IS INSULIN GLARGINE A COST-EFFECTIVE OPTION FOR TREATMENT OF PATIENTS NA AND AGE BELOW 65YEARS IN COMPARISON TO NPH AND PREMIX IN POLAND?

Abstract

Authors

P McEwan A Woehl P Kawalec J Lis J Gierczynski J Walczak

Back to Volume 11, Issue 6

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now